1. Exploring the Shared Pathogenesis Mechanisms of Endometriosis and Cancer: Stemness and Targeted Treatments of Its Molecular Pathways-A Narrative Review.
- Author
-
Mitranovici MI, Costachescu D, Voidazan S, Munteanu M, Buicu CF, Oală IE, Ivan V, Apostol A, Melinte IM, Crisan A, Pușcașiu L, and Micu R
- Subjects
- Female, Humans, Molecular Targeted Therapy, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, Signal Transduction, Endometriosis pathology, Endometriosis metabolism, Endometriosis genetics, Endometriosis therapy, Neoplasms genetics, Neoplasms metabolism, Neoplasms pathology, Neoplasms therapy
- Abstract
Endometriosis is a benign disease but with malignant behavior, sharing numerous features with cancers. Endometriosis is the development of endometrial tissue outside the uterus, with the presence of both glands and stroma. Approximately 10% of women of reproductive age suffer from endometriosis; it involves high social costs and affects the patient's quality of life. In this review, we attempt to capture the pathogenesis mechanisms that are common to endometriosis and cancer based on molecular biology, focusing more on the principle of immunological changes and stemness. Clinical applicability will consist of targeted treatments that represent future directions in these diseases, which impose a burden on the healthcare system. Unlike endometriosis, cancer is a disease with fatal evolution, with conventional treatment based on chemo/radiotherapy. Here, we focus on the niche of personalized treatments that target molecular pathways. Our findings show that, in both pathologies, the resistance to treatments is due to the stemness of the stem cells, which might play a role in the appearance and evolution of both diseases. More research is needed before we can draw firm conclusions.
- Published
- 2024
- Full Text
- View/download PDF